Cookies

Like most websites The Cannabis Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

May 2019 Issue of The Cannabis Scientist

This month we explore the pharmaceutical industry's increasing interest in cannabis-derived medicines, and the unique challenges posed by translating cannabinoids into prescription drugs. Plus, we cover the latest hot topics in the field – synthetic cannabinoids, mental health effects and the need for rigorous testing – and sit down with Reggie Gaudino to discuss his journey to becoming a guru of cannabis genetics and intellectual property.

Register to download
Register here to download any issue of The Cannabis Scientist for FREE.
Login
Receive content, products, events as well as relevant industry updates from The Cannabis Scientist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Articles featured in this issue

Business & Profession Business

Under Attack

| Rich Whitworth

The cannabis universe is evolving rapidly, but how will newcomers shape the field?

Research & Development Neurology & psychology

Fishing for Answers

| Matthew Hallam

Cannabinoid receptor 2 exerts behavioural effects in zebrafish - and may do in humans, too.

Research & Development Adverse effects

I Wanna Be Sedated

| Matthew Hallam

Does cannabis counteract medical sedation?

Research & Development Adverse effects

Cannabis on the Brain

| Matthew Hallam

Does cannabis use impact long-term mental health? New research suggests that it just might.

Research & Development Medical research

Dawn of the (Synthetic) Dope

| Matthew Hallam

Synthetic cannabinoids have become ubiquitous, but how do they exert their 'zombifying' effects?

Business & Profession Business

In the News...

| Matthew Hallam

Get up to speed on some of the latest cannabis content hitting headlines.

Business & Profession Pesticide analysis

Time for Testing

| Sponsored by Waters

Cannabis testing: regulation, evolution and the need for nuanced debate.

Research & Development Pharmaceutical

Pharma Takeover: Under Construction?

| James Strachan

The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave?

Testing & Processing Omics

The Genetics – and IP – Guru

| Reggie Gaudino

Reggie Gaudino on sequencing strains and the storm brewing in cannabis IP

Other issues of 2019